Clinical trial · people

Pramlintide pump infusion: HbA1c fell 0.35% in 16-week pilot

Checked against the paper Clinical trialPublished by PepVault

The takeaway

Early, small-scale evidence that pump-delivered pramlintide in type 1 diabetes lowered fasting glucose and mealtime insulin needs, with mild low blood sugar after meals in everyone.

Kind
Clinical trial
Studied in
People
Number studied
11
Published
2009
Journal
Endocr Pract

What they tested

The team wanted to see whether giving pramlintide through a pump, as a steady background dose plus extra doses before meals, works and is safe in people with type 1 diabetes.

How the study was done

An open-label, single-arm pilot trial (everyone got the drug, everyone knew it, and there was no comparison group) in 11 adults with long-standing type 1 diabetes who already used insulin pumps, run for 16 weeks. Insulin doses were lowered by 10% when pramlintide started and then adjusted to avoid low blood sugar.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

After 16 weeks, average HbA1c (a 3-month average of blood sugar) went from 8.20% to 7.85%, a drop of 0.35%. Fasting glucose fell from 198.2 to 135.8 mg/dL, and weight was down 0.5 kg at week 12. The daily mealtime insulin dose fell 20%, while background insulin stayed the same at 27.7 U. Every patient had mild low blood sugar after meals but none had severe episodes, and 3 of the 11 had mild nausea early on.

What it doesn’t show

This was a very small, short pilot with no control group, so the changes can't be firmly credited to pramlintide. The authors called for larger studies.

The paper

Huffman et al. Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study. Endocr Pract. 2009.

The compound

More studies on Pramlintide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo